ASGE Postgraduate Course at ACG 2022: Expanding the Scope of Fundamental and Advanced Endoscopy | October 2022-Point Counterpoint: Malignant Gastric Outlet Obstruction. EUS Guided Gastro-Jejunostomy Is the Preferred Endoscopic Therapy in 2022

Point Counterpoint: Malignant Gastric Outlet Obstruction. EUS Guided Gastro-Jejunostomy Is the Preferred Endoscopic Therapy in 2022

Back to course

Video Transcription

Video Summary

In this video, Mwenke Shab from Johns Hopkins discusses the use of endoscopic ultrasound-guided gastrojejunostomy (EUS-GJ) as a preferred therapy for malignant gastric outlet obstruction. Shab explains that current options such as duodenal stenting and surgical GJ have limitations, including tissue ingrowth and significant morbidity. EUS-GJ offers advantages such as stenting away from the tumor and providing a minimally invasive option. Shab demonstrates the technique using a direct EUS-GJ approach and highlights the importance of proper deployment and classification of stents. He concludes by stating that while EUS-GJ is still in its early stages and presents technical challenges, the future looks promising with the development of devices that can make the procedure easier.

Asset Subtitle

Mouen A. Khashab, MD, MASGE

Keywords

endoscopic ultrasound-guided gastrojejunostomy

EUS-GJ

malignant gastric outlet obstruction

duodenal stenting

surgical GJ